AAAAAA
Results:
1-17
|
Results: 17
Authors:
Sever, PS
Dahlof, B
Poulter, NR
Wedel, H
Beevers, G
Caulfield, M
Collins, R
Kjeldsen, SE
McInnes, GT
Mehlsen, J
Nieminen, M
O'Brien, E
Ostergren, J
Citation: Ps. Sever et al., Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol, J HUM HYPER, 15, 2001, pp. S11-S12
Authors:
O'Brien, E
McInnes, GT
Stanton, A
Thom, S
Caulfield, M
Atkins, N
Nichol, FM
Citation: E. O'Brien et al., Ambulatory blood pressure monitoring and 24-h blood pressure control as predictors of outcome in treated hypertensive patients, J HUM HYPER, 15, 2001, pp. S47-S51
Authors:
McInnes, GT
Citation: Gt. Mcinnes, Lessons from the recent trials on hypertension treatment, NEPH DIAL T, 16, 2001, pp. 43-45
Authors:
Sever, PS
Dahlof, B
Poulter, NR
Wedel, H
Beevers, G
Caulfield, M
Collins, R
Kjeldsen, SE
McInnes, GT
Mehlsen, J
Nieminen, M
O'Brien, E
Ostergren, J
Citation: Ps. Sever et al., Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial, J HYPERTENS, 19(6), 2001, pp. 1139-1147
Authors:
Zanchetti, A
Hansson, L
Dahlof, B
Elmfeldt, D
Kjeldsen, S
Kolloch, R
Larochelle, P
McInnes, GT
Mallion, JM
Ruilope, L
Wedel, H
Citation: A. Zanchetti et al., Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study, J HYPERTENS, 19(6), 2001, pp. 1149-1159
Authors:
Lever, AF
McInnes, GT
Brennan, PJ
Millar, JA
Ramsay, LE
Citation: Af. Lever et al., The MRC trial of treatment in mild hypertension, CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 97-126
Authors:
McInnes, GT
O'Kane, KPJ
Istad, H
Keinanen-Kiukaanniemi, S
Van Mierlo, HFCM
Citation: Gt. Mcinnes et al., Comparison of the AT(1)-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients, J HUM HYPER, 14(4), 2000, pp. 263-269
Authors:
McInnes, GT
Mancia, G
Sever, PS
Poulter, NR
Citation: Gt. Mcinnes et al., Applying evidence-based medicine to current practice: a round table panel discussion, J HUM HYPER, 14, 2000, pp. S17-S22
Authors:
McInnes, GT
Citation: Gt. Mcinnes, Diuretics, SIDE EFFECT, 23, 2000, pp. 225-230
Authors:
Lever, AF
Beevers, DG
Hole, DJ
Isles, CG
Meredith, PA
Murray, LS
McInnes, GT
Reid, JL
Citation: Af. Lever et al., Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?, CLIN EXP HY, 21(5-6), 1999, pp. 553-562
Authors:
Lever, AF
Hole, DJ
Gillis, CR
McInnes, GT
Meredith, PA
Murray, LS
Reid, JL
Citation: Af. Lever et al., Is cancer related to hypertension or to its treatment?, CLIN EXP HY, 21(5-6), 1999, pp. 937-946
Authors:
Bateman, DN
McInnes, GT
Webb, DJ
Citation: Dn. Bateman et al., Clinical pharmacology and therapeutics in a changing world, BR J CL PH, 48(1), 1999, pp. 1-3
Authors:
Waeber, B
Leonetti, G
Kolloch, R
McInnes, GT
Citation: B. Waeber et al., Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study, J HYPERTENS, 17(7), 1999, pp. 1041-1045
Authors:
McInnes, GT
Citation: Gt. Mcinnes, Angiotensin II antagonism in clinical practice: Experience with valsartan, J CARDIO PH, 33, 1999, pp. S29-S32
Authors:
McInnes, GT
Citation: Gt. Mcinnes, Clinical advantage of valsartan, CARDIOLOGY, 91, 1999, pp. 14-18
Authors:
McInnes, GT
Citation: Gt. Mcinnes, Integrated approaches to management of hypertension: Promoting treatment acceptance, AM HEART J, 138(3), 1999, pp. S252-S255
Authors:
McInnes, GT
Citation: Gt. Mcinnes, Diuretics, SIDE EFFECT, 21, 1998, pp. 226-231
Risultati:
1-17
|